Amaryl 4mg tablets

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Glimepiride

Disponibbli minn:

Zentiva Pharma UK Ltd

Kodiċi ATC:

A10BB12

INN (Isem Internazzjonali):

Glimepiride

Dożaġġ:

4mg

Għamla farmaċewtika:

Oral tablet

Rotta amministrattiva:

Oral

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 06010201; GTIN: 5013841201784

Fuljett ta 'informazzjoni

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
pharmacist.
• This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if
their symptoms are the same as yours.
• If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet.
WHAT IS IN THIS LEAFLET
1. What Amaryl is and what it is used for
2. What you need to know before you take Amaryl
3. How to take Amaryl
4. Possible side effects
5. How to store Amaryl
6. Contents of the pack and other information
Amaryl is a medicine taken by mouth to help lower blood
sugar. It belongs to a group of medicines called
sulfonylureas.
Amaryl works by increasing the amount of insulin released
from your pancreas. The insulin then lowers your blood
sugar levels.
WHAT AMARYL IS USED FOR:
• Amaryl is used to treat a certain form of diabetes (type 2
diabetes mellitus) when diet, physical exercise and weight
reduction alone have not been able to control your blood
sugar levels.
• You are allergic to: glimepiride or other sulfonylureas
(medicines used to lower your blood sugar such as
glibenclamide) or sulfonamides (medicines for bacterial
infections such as sulfamethoxazole) or any of the other
ingredients of this medicine (listed in section 6)
• You have insulin dependent diabetes (type 1 diabetes
mellitus)
• You have diabetic ketoacidosis (a complication of diabetes
when your acid level is raised in your body and you may
have some of the following signs: fatigue, feeling sick
(nausea), frequent urination and muscular stiffness)
• You are in a diabetic coma
• You have severe kidney disease
• You have a severe liver disease
Do not take this medicine if any of the above apply to you.
If you are not sure, talk to your doctor or pharmacist
before taking Amaryl.
TALK TO YOUR DOC

Karatteristiċi tal-prodott

AMARYL 4MG TABLETS
Summary of Product Characteristics Updated 06-Nov-2013 | Zentiva
1. Name of the medicinal product
Amaryl 4 mg, tablet
2. Qualitative and quantitative composition
[Each tablet contains 4 mg glimepiride.]
Excipients: also contains 135.9 mg lactose monohydrate per tablet.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet
The tablets are light blue, oblong and scored on both sides.
The tablets can be divided into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Amaryl is indicated for the treatment of type 2 diabetes mellitus,
when diet, physical exercise and weight
reduction alone are not adequate.
4.2 Posology and method of administration
For oral administration
The basis for successful treatment of diabetes is a good diet, regular
physical activity, as well as routine
checks of blood and urine. Tablets or insulin cannot compensate if the
patient does not keep to the
recommended diet.
Posology
Dose is determined by the results of blood and urinary glucose
determinations.
The starting dose is 1 mg glimepiride per day. If good control is
achieved this dose should be used for
maintenance therapy.
For the different dose regimens appropriate strengths are available.
If control is unsatisfactory the dose should be increased, based on
the glycaemic control, in a stepwise
manner with an interval of about 1 to 2 weeks between each step, to 2,
3 or 4 mg glimepiride per day.
A dose of more than 4 mg glimepiride per day gives better results only
in exceptional cases. The
maximum recommended dose is 6 mg glimepiride per day.
In patients not adequately controlled with the maximum daily dose of
metformin, concomitant
glimepiride therapy can be initiated.
While maintaining the metformin dose, the glimepiride therapy is
started with a low dose, and is then
titrated up depending on the desired level of metabolic control up to
the maximum daily dose. The
combination therapy should be initiated under close medical
supervision.
In patients not adequately controlled with t